Immunoglobulins Global Market Report 2025

Description

Immunoglobulins, also known as antibodies, are glycoproteins produced by plasma cells, a type of white blood cell. These molecules play a crucial role in the immune response by selectively identifying and binding to specific antigens, such as viruses or bacteria, contributing to their elimination from the body.

The primary types of immunoglobulins include IgG, IgA, IgM, IgE, and IgD. Immunoglobulin G (IgG) is particularly significant as it is the main stimulator of humoral immunity in extracellular fluids like blood, lymph, and saliva. Each type of immunoglobulin serves a distinct function in the immune system's defense against various pathogens. These immunoglobulins are administered through different modes of delivery, including intravenous and subcutaneous routes. They find applications in treating conditions such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency diseases, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), and others. The therapeutic use of immunoglobulins helps address deficiencies in the immune system and manage autoimmune disorders, enhancing the body's ability to fight infections and maintain overall health.

The immunoglobulins market research report is one of a series of new reports from The Business Research Company that provides immunoglobulins market statistics, including immunoglobulins industry global market size, regional shares, competitors with a immunoglobulins market share, detailed immunoglobulins market segments, market trends and opportunities, and any further data you may need to thrive in the immunoglobulins industry. This immunoglobulins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoglobulins market size has grown strongly in recent years. It will grow from $18.85 billion in 2024 to $20.53 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.

The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $31.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.

The growth of the immunoglobulins market is being propelled by the increasing geriatric population. This demographic is particularly susceptible to infectious and autoimmune diseases. Immunoglobulin tests are instrumental in assessing the body's ability to generate antibodies for safeguarding against bacteria, viruses, and allergies. For example, a report from the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally is projected to be 60 years or older. Additionally, it is estimated that by 2050, the worldwide population of individuals aged 60 or older will reach 2. 1 billion. Consequently, the rising geriatric population is anticipated to drive demand for the immunoglobulins market throughout the forecast period.

The anticipated growth of the immunoglobulins market is further supported by an increase in healthcare expenditure. Healthcare expenditure encompasses the total financial outlay by individuals, organizations, and governments on healthcare-related services, treatments, medications, medical equipment, facilities, and healthcare administration. Elevated investment in the healthcare sector fosters research and development activities in immunoglobulins, potentially leading to the discovery of advanced therapies and augmenting market growth. A report published by the Centers for Medicare & Medicaid Services in March 2022 estimated an average annual increase of 5. 1% in national health spending between 2021 and 2030, reaching nearly $6. 8 trillion. Moreover, Medicare and Medicaid spending is projected to rise at annual rates of 7. 2% and 5. 6%, respectively, during the same period. Consequently, the escalating healthcare expenditure is a driving force behind the growth of the immunoglobulins market.

Major companies in the immunoglobulins market are creating innovative products, such as intravenous immunoglobulins, to cater to larger customer bases, drive sales, and boost revenue. For example, in September 2024, GC Biopharma, a South Korean biotechnology company, launched ALYGLO(TM) (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, aimed at treating primary humoral immunodeficiency (PI) in adults aged 17 and older. This product is now available to patients through specialty pharmacies. The launch is notable as the U.S. is the largest immunoglobulin market globally, valued at around $11.6 billion. GC Biopharma targets $50 million in sales for ALYGLO in its first year, with plans to escalate this to $300 million by 2028. This ambitious growth strategy includes forming partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are vital for the effective distribution of immunoglobulin products.

Major companies in the immunoglobulins market are concentrating on strategic partnerships to develop advanced immunoglobulin products. For instance, Biotest, a Germany-based biotechnology company, launched its immunoglobulin product, Yimmugo, in the United States after receiving FDA approval for the treatment of primary immunodeficiencies (PID). This launch is part of a strategic framework established with Kedrion Biopharma for a long-term distribution agreement anticipated to generate over $1 billion in revenue over seven years. The partnership requires Biotest to supply minimum quantities of Yimmugo, with preparations for its market introduction planned for 2025. This collaboration leverages Kedrion's extensive experience in the immunoglobulin market, addressing the needs of around 500,000 PID patients in the U.S. The agreement not only positions Biotest to expand its presence in the growing immunoglobulin market but also improves patient access to essential therapies.

In October 2022, AbbVie Inc., a US-based pharmaceutical company, completed the acquisition of DJS Antibodies Ltd. for an undisclosed amount. This strategic move is expected to enhance AbbVie's existing antibody research efforts, strengthen its immunology portfolio, and establish a significant presence in the bioscience hub of Oxford, UK. The acquisition provides AbbVie with access to the HEPTAD platform, complementing its robust capabilities in biotherapeutics research. Simultaneously, DJS plans to leverage AbbVie's extensive expertise in drug discovery to advance antibody therapeutics and explore novel biological insights, particularly in challenging targets like GPCRs that have proven resistant to biologics-based approaches. DJS Antibodies Ltd. is a UK-based company specializing in antibody therapeutics.

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The immunoglobins market consists of sales of antibodies, glycoproteins, and antigens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoglobulins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoglobulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoglobulins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunoglobulins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: IGG; IGA; IGM; IGE; IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery; Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia; Chronic Inflammatory demyelinating polyneuropathy (CIDP); Immunodeficiency Disease; Myasthenia Gravis; Idiopathic thrombocytopenic purpura (ITP); Other Applications
Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin); SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA; Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM; Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE; Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD; Monoclonal IGD
Companies Mentioned: Baxter International Inc.; CSL Behring LLC; Grifols S. A.; Octapharma AG; China Biologic Products Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21630

1. Executive Summary

2. Immunoglobulins Market Characteristics

3. Immunoglobulins Market Trends And Strategies

4. Immunoglobulins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Immunoglobulins Growth Analysis And Strategic Analysis Framework

5.1. Global Immunoglobulins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Immunoglobulins Market Growth Rate Analysis
5.4. Global Immunoglobulins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Immunoglobulins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Immunoglobulins Total Addressable Market (TAM)

6. Immunoglobulins Market Segmentation

6.1. Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
IGG
IGA
IGM
IGE
IGD
6.2. Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Mode of Delivery
Subcutaneous Mode of Delivery
6.3. Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypogammaglobulinemia
Chronic Inflammatory demyelinating polyneuropathy (CIDP)
Immunodeficiency Disease
Myasthenia Gravis
Idiopathic Thrombocytopenic Purpura (ITP)
Other Applications
6.4. Global Immunoglobulins Market, Sub-Segmentation Of IGG (Immunoglobulin G), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
IVIG (Intravenous Immunoglobulin)
SCIG (Subcutaneous Immunoglobulin)
6.5. Global Immunoglobulins Market, Sub-Segmentation Of IGA (Immunoglobulin A), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal IGA
Polyvalent IGA
6.6. Global Immunoglobulins Market, Sub-Segmentation Of IGM (Immunoglobulin M), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal IGM
Polyvalent IGM
6.7. Global Immunoglobulins Market, Sub-Segmentation Of IGE (Immunoglobulin E), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergen-Specific IGE
Monoclonal IGE
6.8. Global Immunoglobulins Market, Sub-Segmentation Of IGD (Immunoglobulin D), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research-Use IGD
Monoclonal IGD

7. Immunoglobulins Market Regional And Country Analysis

7.1. Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunoglobulins Market

8.1. Asia-Pacific Immunoglobulins Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunoglobulins Market

9.1. China Immunoglobulins Market Overview
9.2. China Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunoglobulins Market

10.1. India Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunoglobulins Market

11.1. Japan Immunoglobulins Market Overview
11.2. Japan Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunoglobulins Market

12.1. Australia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunoglobulins Market

13.1. Indonesia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunoglobulins Market

14.1. South Korea Immunoglobulins Market Overview
14.2. South Korea Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunoglobulins Market

15.1. Western Europe Immunoglobulins Market Overview
15.2. Western Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunoglobulins Market

16.1. UK Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunoglobulins Market

17.1. Germany Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunoglobulins Market

18.1. France Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunoglobulins Market

19.1. Italy Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunoglobulins Market

20.1. Spain Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunoglobulins Market

21.1. Eastern Europe Immunoglobulins Market Overview
21.2. Eastern Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunoglobulins Market

22.1. Russia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunoglobulins Market

23.1. North America Immunoglobulins Market Overview
23.2. North America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunoglobulins Market

24.1. USA Immunoglobulins Market Overview
24.2. USA Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunoglobulins Market

25.1. Canada Immunoglobulins Market Overview
25.2. Canada Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunoglobulins Market

26.1. South America Immunoglobulins Market Overview
26.2. South America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunoglobulins Market

27.1. Brazil Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunoglobulins Market

28.1. Middle East Immunoglobulins Market Overview
28.2. Middle East Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunoglobulins Market

29.1. Africa Immunoglobulins Market Overview
29.2. Africa Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunoglobulins Market Competitive Landscape And Company Profiles

30.1. Immunoglobulins Market Competitive Landscape
30.2. Immunoglobulins Market Company Profiles
- 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Grifols S. A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunoglobulins Market Other Major And Innovative Companies

31.1. Kedrion SpA
31.2. LFB SA
31.3. Biotest AG
31.4. Sanquin Blood Supply Foundation
31.5. ADMA Biologics Inc.
31.6. Option Care Health Inc.
31.7. Shanghai RAAS Blood Products Co. Ltd.
31.8. Antibody Solutions
31.9. Bio Products Laboratory Ltd.
31.10. Immunovant Inc.
31.11. Kamada Ltd.
31.12. Emergent BioSolutions Inc.
31.13. Fresenius Kabi AG
31.14. GlaxoSmithKline plc
31.15. Pfizer Inc.

32. Global Immunoglobulins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulins Market

34. Recent Developments In The Immunoglobulins Market

35. Immunoglobulins Market High Potential Countries, Segments and Strategies

35.1 Immunoglobulins Market In 2029 - Countries Offering Most New Opportunities
35.2 Immunoglobulins Market In 2029 - Segments Offering Most New Opportunities
35.3 Immunoglobulins Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer